Five-year follow-up of patients who underwent everolimus-eluting bioresorbable scaffold implantation
Wiebe J, Hofmann FJ, Doerr O, Bauer T, Boeder N, Liebetrau C, Blachutzik F, Moellmann H, Elsaesser A, Achenbach S, Hamm CW, Nef HM (2020)
Publication Type: Journal article
Publication year: 2020
Journal
DOI: 10.1002/ccd.28843
Abstract
Objectives The aim of this study was to evaluate very long-term results after unrestricted everolimus-eluting bioresorbable scaffolds (BRS) implantation.
Authors with CRIS profile
Involved external institutions
Technische Universität München (TUM)
Germany (DE)
Justus-Liebig-Universität Gießen
Germany (DE)
Kerckhoff-Klinik
Germany (DE)
St.-Johannes-Hospital
Germany (DE)
Klinikum Oldenburg
Germany (DE)
Germany (DE)
Justus-Liebig-Universität Gießen
Germany (DE)
Kerckhoff-Klinik
Germany (DE)
St.-Johannes-Hospital
Germany (DE)
Klinikum Oldenburg
Germany (DE)
How to cite
APA:
Wiebe, J., Hofmann, F.J., Doerr, O., Bauer, T., Boeder, N., Liebetrau, C.,... Nef, H.M. (2020). Five-year follow-up of patients who underwent everolimus-eluting bioresorbable scaffold implantation. Catheterization and Cardiovascular Interventions. https://doi.org/10.1002/ccd.28843
MLA:
Wiebe, Jens, et al. "Five-year follow-up of patients who underwent everolimus-eluting bioresorbable scaffold implantation." Catheterization and Cardiovascular Interventions (2020).
BibTeX: Download